Knowledge Distillery

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind,…

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind,…

A Randomized Trial of Convalescent Plasma in COVID-19 Severe Pneumonia

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with COVID-19

Remdesivir for the Treatment of Covid-19 — Final Report

Efficacy of Tocilizumab in Patients Hospitalized with COVID-19

Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers A Randomized Clinical Trial

In this double-blind, randomised, placebo-controlled phase 3 trial the authors present the interim efficacy and safety results of a phase 3 clinical…

Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre…

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial

Tofacitinib in Patients Hospitalized with COVID-19 Pneumonia

Immunogenicity of the Ad26.COV2.S vaccine for COVID-19